NEW DELHI: A historic nationwide pharmacy strike orchestrated by the All India Organisation of Chemists and Druggists (AIOCD) achieved an unprecedented shutdown of India’s private healthcare supply chain. Over 12.4 lakh traditional brick-and-mortar retail chemists and distributors completely closed down operations from 6:00 AM to midnight to protest against unregulated digital e-pharmacies and corporate “quick-commerce” delivery platforms. The near-total trade freeze successfully brought private retail medicine distributions to a temporary standstill, creating logistical hurdles for out-of-hospital patient care.
[Unregulated Rise of E-Pharmacies & Quick-Commerce Apps]
│
▼
[Traditional Retail Shuts: 12.4 Lakh Outlets Down Shutters]
│
┌─────────────────────────────┴─────────────────────────────┐
▼ ▼
[Severe Supply Strain on Outpatients] [Special Emergency Desks Maintained]
│ │
▼ ▼
[Doctors Urged to Guard Prescriptions] [Hospital and Jan Aushadhi Open]
The Regulatory Conflict: Demanding the Rollback of GSR Notifications
The core of the retail pharmacy strike centres on long-standing legal loopholes that traditional traders claim threaten the livelihood of five crore individuals linked to the pharma sector. Led by AIOCD National President Jagannath Shinde and General Secretary Rajiv Singhal, the trade union is demanding an immediate government rollback of temporary relaxations introduced during the COVID-19 pandemic.
Specifically, the association has targeted two highly controversial regulatory notifications: G.S.R. 220(E) and G.S.R. 817(E). Protesting groups argue these notifications allow corporate-backed online platforms to exploit a legal gray area, bypassing physical inspection checks mandated under the outdated Drugs and Cosmetics Act.
Furthermore, traditional retailers argue that venture-capital-funded digital applications engage in predatory pricing, offering deep discounts ranging from 20% to 60%. Retail chemists cannot match these under the strict Drug Price Control Order (DPCO), creating an uneven economic landscape.
Clinical Impact and Emergency Contingency Measures
For medical practitioners in India, the single-day bandh presented a logistical challenge in patient care, particularly regarding chronic disease management and immediate outpatient therapies. However, the AIOCD and its regional chapters intentionally coordinated safeguards to avoid a full-scale public health crisis.
While independent main-street shops were entirely locked, pharmacies attached directly to private hospitals, corporate chains like Apollo and MedPlus, and state-run Jan Aushadhi Kendras remained operational. In states like Gujarat and Maharashtra, the local associations established dedicated, round-the-clock emergency medicine counters across select urban pockets to handle urgent medical requirements. Despite these safety valves, thousands of outpatients clutching fresh hospital prescriptions were left searching for open retail stores across major cities like Hyderabad, Pune, and Bhubaneswar.
Critical Clinical Takeaways for Indian Clinicians
The massive scope of this trade strike highlights several emerging risks and practice realities for doctors across India:
- The Threat of Prescription Recycling and AI Forgery: A primary clinical justification for the strike is the unchecked reuse of doctor prescriptions on digital platforms. Chemists warned that unregulated apps accept unverified or AI-generated prescription copies multiple times. Doctors should consider shifting to secure, unique digital signatures or time-stamped prescriptions to prevent unauthorized refills.
- Accelerating Antimicrobial Resistance (AMR): Retailers highlighted that digital delivery apps often supply potent Schedule H and H1 antibiotics without verifying physical prescriptions. For clinicians, this lax digital distribution undermines strict national antibiotic stewardship programs, directly worsening the AMR crisis across communities.
- Counseling on Chronic Therapy Refills: With trade unions threatening further indefinite agitations if the Ministry of Health fails to intervene, clinicians must proactively counsel patients on chronic therapies—such as cardiology, endocrinology, and oncology regimens—to maintain a 7-to-10-day backup stock of essential medicines.
- Patient Vulnerability to Counterfeit Supply Chains: Traditional chemists allege that loose online verification standards open the door for substandard or counterfeit formulations to slip into the supply chain. Doctors should advise patients to purchase critical, narrow-therapeutic-index medications exclusively from verified, traceable distribution channels.
As the AIOCD submits comprehensive memorandums directly to the Prime Minister’s Office through district collectorates, the medical community continues to push for a balanced regulatory solution. While e-commerce brings convenience, clinicians emphasize that digital platforms must be held to the same rigorous oversight as traditional pharmacies to safeguard patient health and maintain prescribing authority.
